NGVT icon

Ingevity

42.01 USD
-1.19
2.75%
At close Jun 13, 4:00 PM EDT
After hours
42.01
+0.00
0.00%
1 day
-2.75%
5 days
-1.38%
1 month
-2.78%
3 months
-3.16%
6 months
-8.34%
Year to date
6.25%
1 year
-8.47%
5 years
-19.07%
10 years
56.40%
 

About: Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.

Employees: 1,600

0
Funds holding %
of 7,296 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

446% more call options, than puts

Call options by funds: $131K | Put options by funds: $24K

109% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 22

33% more repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 75

8% more funds holding

Funds holding: 256 [Q4 2024] → 277 (+21) [Q1 2025]

0.39% less ownership

Funds ownership: 100.65% [Q4 2024] → 100.27% (-0.39%) [Q1 2025]

3% less capital invested

Capital invested by funds: $1.49B [Q4 2024] → $1.45B (-$43.2M) [Q1 2025]

50% less funds holding in top 10

Funds holding in top 10: 2 [Q4 2024] → 1 (-1) [Q1 2025]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$38
10%
downside
Avg. target
$38
10%
downside
High target
$38
10%
downside

1 analyst rating

positive
0%
neutral
100%
negative
0%
Wells Fargo
Michael Sison
10%downside
$38
Equal-Weight
Maintained
7 May 2025

Financial journalist opinion

Positive
Zacks Investment Research
1 week ago
Why Is Ingevity (NGVT) Up 6.4% Since Last Earnings Report?
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock?
Why Is Ingevity (NGVT) Up 6.4% Since Last Earnings Report?
Neutral
Zacks Investment Research
1 month ago
Ingevity Q1 Earnings Up, Revenues Down Y/Y on Repositioning Actions
NGVT's earnings increase, but revenues are impacted by the Performance Chemical segment's repositioning measures.
Ingevity Q1 Earnings Up, Revenues Down Y/Y on Repositioning Actions
Neutral
Seeking Alpha
1 month ago
Ingevity Corporation (NGVT) Q1 2025 Earnings Call Transcript
Ingevity Corporation (NYSE:NGVT ) Q1 2025 Results Conference Call May 6, 2025 9:00 AM ET Company Participants John Nypaver - Vice President, Treasurer & Investor Relations David Li - President & Chief Executive Officer Mary Dean Hall - Executive Vice President & Chief Financial Officer Conference Call Participants John McNulty - BMO Capital Markets Jon Tanwanteng - CJS Securities Daniel Rizzo - Jefferies Abigail Eberts - Wells Fargo Securities Operator Good morning or good afternoon. I welcome to the Ingevity First Quarter 2025 Earnings Call and Webcast.
Ingevity Corporation (NGVT) Q1 2025 Earnings Call Transcript
Neutral
Business Wire
1 month ago
Ingevity reports first quarter 2025 financial results
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity Corporation (NYSE: NGVT) today reported its financial results for the first quarter of 2025.
Ingevity reports first quarter 2025 financial results
Neutral
Business Wire
1 month ago
Ingevity announces dates for first-quarter 2025 earnings release and webcast
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity announces dates for first-quarter 2025 earnings release and webcast.
Ingevity announces dates for first-quarter 2025 earnings release and webcast
Positive
Zacks Investment Research
2 months ago
Here's Why You Should Add Ingevity Stock to Your Portfolio
NGVT benefits from the repositioning of its Performance Chemicals segment, strategic acquisitions and actions to drive growth.
Here's Why You Should Add Ingevity Stock to Your Portfolio
Positive
Zacks Investment Research
2 months ago
Ingevity's Shares Up 10% in 6 Months: What's Driving the Stock?
NGVT gains on the repositioning of its Performance Chemicals segment, strategic acquisitions and actions to drive growth.
Ingevity's Shares Up 10% in 6 Months: What's Driving the Stock?
Neutral
Business Wire
2 months ago
Ingevity Files Definitive Proxy Statement and Issues Letter to Stockholders
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity today announced that it has filed its definitive proxy statement with the U.S. SEC in connection with its 2025 Annual Meeting.
Ingevity Files Definitive Proxy Statement and Issues Letter to Stockholders
Negative
Zacks Investment Research
2 months ago
Why Is Ingevity (NGVT) Down 8.3% Since Last Earnings Report?
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock?
Why Is Ingevity (NGVT) Down 8.3% Since Last Earnings Report?
Positive
Zacks Investment Research
3 months ago
Why Ingevity (NGVT) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Ingevity (NGVT) is a Top Momentum Stock for the Long-Term
Charts implemented using Lightweight Charts™